Berkshire Trims DaVita Stake in Planned Share Repurchase

Berkshire Hathaway, DaVita’s largest institutional investor, has sold 203,091 shares of the dialysis provider, reducing its ownership stake to 45%, according to a regulatory filing on Thursday. The transaction is part of an ongoing share repurchase agreement established between the two companies in April 2024.

Under the agreement, DaVita repurchases shares on a quarterly basis to ensure Berkshire’s stake remains at 45%.